MOESM1 of Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines

Khan, Ishaq; Baeesa, Saleh; Bangash, Mohammed; Schulten, Hans-Juergen; Alghamdi, Fahad; Qashqari, Hanadi; Madkhali, Nawal; Carracedo, Angel; Saka, Mohamad; Jamal, Awatif; Al-Maghrabi, Jaudah; AlQahtani, Mohammed; Al-Karim, Saleh; Damanhouri, Ghazi; Saini, Kulvinder; Chaudhary, Adeel; Abuzenadah, Adel; Hussein, Deema

doi:10.6084/m9.figshare.c.3833335_D1.v1

12935_2017_441_MOESM1_ESM.pptx (79.1 kB)

MOESM1 of Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines

presentation

posted on 2017-07-21, 05:00 authored by Ishaq Khan, Saleh Baeesa, Mohammed Bangash, Hans-Juergen Schulten, Fahad Alghamdi, Hanadi Qashqari, Nawal Madkhali, Angel Carracedo, Mohamad Saka, Awatif Jamal, Jaudah Al-Maghrabi, Mohammed AlQahtani, Saleh Al-Karim, Ghazi Damanhouri, Kulvinder Saini, Adeel Chaudhary, Adel Abuzenadah, Deema Hussein

Additional file 1: Figure S1. Growth inhibition assays for A) Cisplatin and B) Etoposide for NG cell lines Jed38_MN, Jed45_MN and Jed49_MN.

Funding

King Abdulaziz University of Saudi Arabia

History

Usage metrics

Keywords

Meningioma Cancer stem cells Caspase 3 Nestin Ki67 CD133 Sox2 AGR2 Frizzled 9 Vimentin Cisplatin Etoposide Drug resistance

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM1 of Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines

Funding

King Abdulaziz University of Saudi Arabia

History

Usage metrics

Categories

Keywords

Licence

Exports